<DOC>
	<DOC>NCT00741689</DOC>
	<brief_summary>The purpose of this study is to assess safety and tolerability of AZD1656 after single ascending oral doses in Japanese healthy male subjects</brief_summary>
	<brief_title>A Study to Evaluate Safety and Tolerability After Single Oral Dosing of AZD1656 in Japanese Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy Japanese males aged ≥20 and ≤40 years of age Clinically normal physical findings and laboratory values as judged by the investigator including negative test of Hepatitis B surface antigen, antibodies to HIV virus and antibodies to Hepatitis C virus Clinically significant illness or clinically relevant trauma, as judged by the investigator, within two weeks before the first administration of the IP History of psychiatric or somatic disease/condition that may interfere with the objectives of the study, as judged by the investigator.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Japanese</keyword>
	<keyword>healthy</keyword>
	<keyword>volunteers</keyword>
</DOC>